| Term 
 | Definition 
 
        | Eimeria Isospora   Affects growth of animal-young animals more seriously than adults (7-14 day old pigs, calves, puppies)   Treatment and prevention difficult |  | 
        |  | 
        
        | Term 
 
        |      Anticoccidials in mammals |  | Definition 
 
        | Decoquinate Na+, H+-ionophores: monensin, lasalocid Amprolium Antifolates Triazine derivatives: Idiclazuril (Clinacox), ponazuril (Marquis) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Coccidistat (not -cidal) Effective vs. sporozoites decreased electron transport   ADM: 0.5 mg/kg/d in cattle feed for about 4 weeks PK: Poor absorption after oral dosing No preslaughter withdrawal Adverse effects: None   |  | 
        |  | 
        
        | Term 
 
        | Ionophores: monensin, lasalocid |  | Definition 
 
        | Isolated from Steptomyces spp. Anticoccial activity vs all coccidia (1st generation trophozoites, merozoites) Growth promotant in ruminants 
 MOA: increased Na+, H+ entry-> 1. Disrupts mictochondria 2. Disrupts Golgi 3. Increased osmolarity 4. decreased pH
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 0.3-1 mg/kg/d in cattle feed for prevention |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | no information in mammals in chickens monensin t1/2=2 hours, lasalocid t1/2=11 h   No preslaughter withdrawal Do not use in calves Can be used in lactating cows |  | 
        |  | 
        
        | Term 
 
        | Ionophores adverse effects |  | Definition 
 
        | increased Na+ entry=cell death increased Na+ entry=increased Ca2+ entry into cells increased myocardial contractility increased Catecholamine release degeneration of myocardium monensin > lasalocid (horses!!!)   Mix thoroughly! Protect workers! |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Quaternary compound thiamine antagonist coccidia are 50X more sensitive than animal cells Effective vs 1st generation trophozoites, schizonts   Drug resistance: drug combination |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 5 mg/kg/d in cattle feed for prevention |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Poor absorption after oral administation   no preslaughter withdrawal |  | 
        |  | 
        
        | Term 
 
        | Amprolium   Adverse effects |  | Definition 
 
        | none at therapeutic doses |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sulfonamides and dihydrofolate reductase inhibitors Longest history for outbreak treatment and prevention Peak activity vs 2nd generation schizonts   Sulfadimethoxine, sulfaquinoxaline, sulfamethazine Ormetoprim, trimethoprim, pyrimethamine, methotrexate Sulfadimethoxine+ormetoprim (Primor, Rofenaid) ADM: 55 mg/kg (d1), then 27.5 mg/kg/d |  | 
        |  | 
        
        | Term 
 
        | Diclazuril   (Clinacox, Protazil) |  | Definition 
 
        | Diclazuril is approved for EPM and avian coccidiosis   For prevention and treatment of coccidiosis Effective vs. coccidia in very young animals (stops oocyst shedding very soon after treatment is initiated)   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | effective vs. schizonts and gametes inhibits nuclear division |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Feed additive: 0.2% Clinacox; 1.56% Protazil   25 mg/kg PO, can redose 15 d later |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Protazil in horses is extralabel   Oral bioavailability: 5%   After oral dosing, Tp=8-24 h   B=43-65 h about 2 days |  | 
        |  | 
        
        | Term 
 
        | Diclazuril   adverse effects |  | Definition 
 
        | Safe when used as directed |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Extra-label for coccidiosis Active metabolite of toltrazuril (sulfone)   Used for EPM, toxoplasmosis   5x's less potent than diclazuril   Ponazuril past-Marquis paste=1 ml=150 mg ponazuril 1ml ponazuril +2 mlH2O->50 mg/ml |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 15-30 mg/kg, PO may repeat after 10 days |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Ponazuril   Adverse effects |  | Definition 
 
        | GI disturbances Hypersensitivity |  | 
        |  | 
        
        | Term 
 
        | 3 anticoccidial drugs used for prevention (not outbreak treatment) |  | Definition 
 
        | Decoquinate Ionophores Amprolium |  | 
        |  | 
        
        | Term 
 
        | 3 Anticoccidial drugs used for prevention and outbreak treatment |  | Definition 
 
        | Antifolates Diclazuril Ponazuril |  | 
        |  | 
        
        | Term 
 
        | Anticoccidial drugs used on a single dose bases |  | Definition 
 
        | Diclazuril (can redose after 15 days)   Ponazuril (can redose after 10 days)   |  | 
        |  | 
        
        | Term 
 
        | Why should diclazuril and ponazuril be used more frequently than other drugs? |  | Definition 
 
        |   They are much newer (less resistance) and work on latter part of the lifecycle   |  | 
        |  | 
        
        | Term 
 
        | Which anticoccidial has least residue problems? |  | Definition 
 
        | Amprolium-no GI absorption |  | 
        |  | 
        
        | Term 
 
        | Which group of anticoccidial drugs is most toxic to animals?   |  | Definition 
 
        | Ionophores-affect myocardium |  | 
        |  | 
        
        | Term 
 
        | Equine Protozoal Myeloencephalitis (EPM) |  | Definition 
 
        | Most important equine protozoal disease in US Sarcocystis neurona infects opossum (definitive host) Small mammals are intermediate host Horse is aberrant, dead-end host Infected by ingestion of sporocysts in contaminated feed/water Schizonts in CNS Clinical signs: head tilt, ataxia, muscle weakness, atrophy, urinary incontinence, constipation (stroke-like) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tx on long term basis 1. Trimethoprim-sulfadiazine, pyrimethamine-sulfadizine (Rebalance), PO, daily for over 30 days 2. Ponazuril (Marquis) PO 5 mg/kg/d for 28-56 days 3. Diclazuril (Protazil) PO 1 mg/kg/d 28 days 4. Anti-inflammatories: flunixin, phenylbutazone, glucocorticoid, DMSO Physical therapy following chemotherapy |  | 
        |  | 
        
        | Term 
 
        | Ponazuril Paste (Marquis) vs EPM   spectrum |  | Definition 
 
        | treatment of coccidiosis, EPM, toxoplasmosis, neosporosis broad spectrum, cross BBB |  | 
        |  | 
        
        | Term 
 
        | Ponazuril paste vs EPM   MOA |  | Definition 
 
        | vs. schizonts by inhibiting nuclear division |  | 
        |  | 
        
        | Term 
 
        | Ponazuril paste vs EPM   ADM |  | Definition 
 
        | 5 mg/kg/d, PO, 4 wk after a grain meal |  | 
        |  | 
        
        | Term 
 
        | Ponazuril paste vs EPM   PK |  | Definition 
 
        | Tp=18d   B=4.5 d (after multiple doses) |  | 
        |  | 
        
        | Term 
 
        | Ponazuril vs EPM   adverse effects |  | Definition 
 
        | blisters on nose and mouth skin rash and hives GI disturbances colic seizures Do not use in sick/debilitated animals due to other disorders   Relapse in 5-30% cases |  | 
        |  | 
        
        | Term 
 
        | Diclazuril (Protazil) vs EPM   formulation |  | Definition 
 
        | pellets as feed additive   similar to ponazuril, more potent |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1 mg/kg/d, PO, 4 wk, mix in grain meal |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Diclazuril vs EPM   adverse effects |  | Definition 
 
        | similar to ponazuril   blisters on nose and mouth, skin rash and hives, GI disturbances, colic, seizures |  | 
        |  | 
        
        | Term 
 
        | Metronidazole (Broad Spectrum) |  | Definition 
 
        | Nitroimidazoles: dimetridazole, ipronidazole, metronidazole   Metranidazole is a human drug   For giardiasis, histomoniasis, babesiosis, trichomoniasis, amebiasis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | disruption of helical structure of DNA by active metabolite (Ferrodoxin-linked M) |  | 
        |  | 
        
        | Term 
 
        | Metronidazole (Flagyl)   ADM |  | Definition 
 
        | 10-30 mg/kg after food, bid or tid for 5-7 days |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | GI absorption, 50-100%   Tp=1 h, widely distributed   excreted in urine in 24 hours: 50% metranidazole, 50% metabolites Oxidation followed by conjugation: excreted in urine in 24 h B=3-5 h |  | 
        |  | 
        
        | Term 
 
        | Metronidazole   adverse effects |  | Definition 
 
        | GI disturbances CNS disturbances Mutagenicity, cardiogenicity Neutropenia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Albendazole and fenbendazole-against giardiasis   Anti-infective with broadest spectrum |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 25 mg/kg, bid for 2 d; after food |  | 
        |  | 
        
        | Term 
 
        | Benzimidazoles   Adverse effects-albendazole |  | Definition 
 
        | may be toxic to liver, bone marrow teratogen |  | 
        |  | 
        
        | Term 
 
        | Control of cryptosporidiosis   3 drugs |  | Definition 
 
        | Paromomycin (Humatin)   Nitrozoxanide (Alinia)-in humas 25 mg/kg, PO, bid, food, 7-28 d   Azithromycin (Zithromax) 15 mg/kg, bid, 14 d |  | 
        |  | 
        
        | Term 
 
        | Paromomycin for cryptosporidiosis |  | Definition 
 
        | an aminoglycoside for extra-label use, very expensive   potential to prevent and treat cryptosporidiosis (125 mg/kg, PO, bid, 5 d) No PK given for animals minimal systemic absorption when given PO   Adverse effects: vomiting, diarrhea, colic, nephrotoxic, deafness |  | 
        |  | 
        
        | Term 
 
        |   Babesiosis   characteristics |  | Definition 
 
        | Protozoans that parasitize RBC's, cause anemia endemic in southern states-Florida, Texas Sporadic cases in horses in Indiana, Wisconsin, Minnesota Ticks-vectors direct animal to animal transmission can occur   Tx with Imidocarb (Imizol) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | binds DNA of babesia and denatures it |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | IM or SC in dogs, 6.6 mg/kg, repeat dose in 2 weeks in horses, for b. caballi: 2 mg/kg x 2d for B. equi, 4 mg/kg, q 72 h x 4   Do not use in food animals |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | readily absorbed from injection site   B=3.5 h   Excreted in urine and feces as parent compound |  | 
        |  | 
        
        | Term 
 
        | Imidocarb   Adverse effects   |  | Definition 
 
        | Injection pain and inflammation 1-7 d   Stimulation of parasympathetic NS, SLUDD (decreased AChE) Teratogenicity and carcinogenicity   Precautions: No cholinergic stimulants don't use in pregnant animals Should use with atropine |  | 
        |  | 
        
        | Term 
 
        | Toxoplasmosis and Neosporosis   |  | Definition 
 
        | Neosporosis->encephalomyelitis in dogs, abortion in cattle Vertical transmission in dogs and cattle Pharmacological control in dogs only     |  | 
        |  | 
        
        | Term 
 
        | Anti-Toxoplasmosis and Anti-Neosporosis Drugs |  | Definition 
 
        | Trimethoprim-sulfadiazine->15 mg/kg, bid 4 wks   Pyrimethamine (0.25-0.5 mg/kg)+sulfadiazine (30 mg/kg), bid, 4 wk   Clindamycin->10-20 mg/kg, PO, IM, bid for 3-6 wk *preferred treatment   Ponazuril 7.5-15 mg/kg/d for 4 wk |  | 
        |  | 
        
        | Term 
 | Definition 
 |